Once an outbreak of pandemic potential has been identified, models have enormous potential to improve the effectiveness of the response. Models can be used to synthesize data to provide enhanced situational awareness, predict the future course of the pandemic, and to plan mitigation strategies.
This publication summarizes two workshops held by the US National Academies of Sciences, Engineering, and Medicine to examine lessons from influenza pandemics and other major outbreaks, understand the extent to which the lessons were learned, and discuss how the lessons could be applied further to ensure that countries are sufficiently ready for future pandemics.
Researchers are now able to take advantage of mobile technologies that can mimic viral properties and combine them with people’s thirst for adventure games. Which means that every student body, housing complex, and workplace could prepare for the public health and sociological implications of an outbreak.
Social science can provide information on social risk factors and mechanisms for disease transmission, local cultural interpretations of disease and response interventions, and the functioning of the health system and local structures of power and authority.
This toolkit consists of a Pandemic Influenza Triage Algorithm to triage patients with influenza-like illness, a Community Site-of Care Tool to determine the appropriate care site for patients based on the Pandemic Influenza Triage Algorithm, and the Community Healthcare Decision Pathway to assess resource and medical surge to determine appropriate care sites.
This review gives an overview of lessons learned from the 1918 influenza pandemic, highlighting new insights into our understanding of viral pathogenesis and their impact on our preparedness for the next outbreak of influenza.
On September 12-14, the US Centers for Disease Control and Prevention (CDC) conducted a pandemic influenza functional exercise in response to a fictional influenza pandemic with federal, state, local, and non-governmental partners.
There is poor public health surveillance in many parts of the world, there aren’t enough vaccines to go around and the international legal framework designed to ensure vaccines get to the poorest countries is not fit for purpose.
The US Food and Drug Administration (FDA) has granted the new drug priority review and said a decision on its approval will be made by the end of this year, meaning it may be ready for the next flu season.
While there are a multitude of new and improved efforts to strengthen global preparedness, there remains an overarching need to make sure residual weak spots are identified and that there is global public accountability.